825 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Downtrend
Article Searches
Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks? https://www.fool.com/investing/2019/01/24/does-johnson-johnsons-grim-outlook-spell-trouble-f.aspx?source=iedfolrf0000001 Jan 24, 2019 - Here's why comments from J&J executives about the future of pharmaceuticals made investors so nervous.
The Zacks Analyst Blog Highlights: Bank of America, Merck, Netflix, IBM and The Bank of New York Mellon http://www.zacks.com/stock/news/348753/the-zacks-analyst-blog-highlights-bank-of-america-merck-netflix-ibm-and-the-bank-of-new-york-mellon?cid=CS-ZC-FT-348753 Jan 22, 2019 - The Zacks Analyst Blog Highlights: Bank of America, Merck, Netflix, IBM and The Bank of New York Mellon
Merck's Partner Gets FDA Nod for Herceptin Biosimilar http://www.zacks.com/stock/news/348729/mercks-partner-gets-fda-nod-for-herceptin-biosimilar?cid=CS-ZC-FT-348729 Jan 21, 2019 - Merck's (MRK) partner, Samsung Bioepis Co. gets FDA approval for Ontruzant, a Herceptin Biosimilar.
Top Analyst Reports for Bank of America, Merck & Netflix http://www.zacks.com/research-daily/206820/top-analyst-reports-for-bank-of-america-merck-netflix?cid=CS-ZC-FT-206820 Jan 21, 2019 - Top Analyst Reports for Bank of America, Merck & Netflix
Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies http://www.zacks.com/stock/news/348354/aeries-aeri-eye-care-candidate-to-enter-clinical-studies?cid=CS-ZC-FT-348354 Jan 18, 2019 - Aerie's (AERI) Investigational New Drug Application for AR-1105 for the treatment of macular edema due to retinal vein occlusion is accepted by the FDA. The candidate will now enter clinical studies.
Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress http://www.zacks.com/stock/news/348304/dow-30-stock-roundup-jpm-axp-earnings-disappoint-gs-unh-impress?cid=CS-ZC-FT-348304 Jan 18, 2019 - The index enjoyed another strong week of gains, increasing over three straight sessions.
Roche's sBLA for Tecentriq-Abraxane Combo Accepted by FDA http://www.zacks.com/stock/news/348232/roches-sbla-for-tecentriq-abraxane-combo-accepted-by-fda?cid=CS-ZC-FT-348232 Jan 17, 2019 - Roche's (RHHBY) sBLA for the label expansion of Tecentriq in combination with Abraxane for the initial treatment of NSCLC has been accepted by the FDA.
Stock Market News For Jan 15, 2019 http://www.zacks.com/stock/news/347445/stock-market-news-for-jan-15-2019?cid=CS-ZC--347445 Jan 15, 2019 - Benchmarks ended in the red on Monday as corporate earnings kicked off.
What's in Store for Merck in 2019 After a Solid Run in '18? http://www.zacks.com/stock/news/347164/whats-in-store-for-merck-in-2019-after-a-solid-run-in-18?cid=CS-ZC-FT-347164 Jan 14, 2019 - Merck (MRK) looks well poised for 2019, carrying forward the momentum achieved last year.
Here Are the 2019 Dogs of the Dow https://www.fool.com/investing/2019/01/13/here-are-the-2019-dogs-of-the-dow.aspx?source=iedfolrf0000001 Jan 13, 2019 - Dividend investors flock to this strategy to simplify their investing and earn solid returns. Here's how to join them this year.

Pages: 1...678910111213141516...83

<<<Page 11>